$CASC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Cascadian Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Cascadian Therapeutics, Inc.. Get notifications about new insider transactions in Cascadian Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 13 2018 | CASC | Cascadian Therapeu ... | Walker Luke Nathaniel | SVP, Clinical Devel ... | Option Exercise | D | 0.00 | 130,000 | 0 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Walker Luke Nathaniel | SVP, Clinical Devel ... | Option Exercise | D | 0.00 | 12,000 | 0 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Walker Luke Nathaniel | SVP, Clinical Devel ... | Option Exercise | D | 0.00 | 7,800 | 0 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Walker Luke Nathaniel | SVP, Clinical Devel ... | Option Exercise | D | 3.99 | 50,000 | 199,500 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Walker Luke Nathaniel | SVP, Clinical Devel ... | Option Exercise | D | 4.64 | 35,100 | 162,864 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Walker Luke Nathaniel | SVP, Clinical Devel ... | Option Exercise | D | 6.90 | 20,834 | 143,755 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Walker Luke Nathaniel | SVP, Clinical Devel ... | Option Exercise | D | 6.90 | 8,334 | 57,505 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Walker Luke Nathaniel | SVP, Clinical Devel ... | Option Exercise | D | 21.06 | 5,834 | 122,864 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Walker Luke Nathaniel | SVP, Clinical Devel ... | Option Exercise | D | 10.56 | 1,250 | 13,200 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Walker Luke Nathaniel | SVP, Clinical Devel ... | Option Exercise | D | 10.44 | 2,500 | 26,100 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Walker Luke Nathaniel | SVP, Clinical Devel ... | Option Exercise | D | 28.44 | 1,250 | 35,550 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Walker Luke Nathaniel | SVP, Clinical Devel ... | Option Exercise | D | 41.52 | 334 | 13,868 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Walker Luke Nathaniel | SVP, Clinical Devel ... | Option Exercise | D | 35.88 | 2,500 | 89,700 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Walker Luke Nathaniel | SVP, Clinical Devel ... | Sell | U | 0.00 | 10,315 | 0 | 0 | 10.3 K to 0 (-100.00 %) |
Mar 13 2018 | CASC | Cascadian Therapeu ... | James Steven P | Director | Option Exercise | D | 0.00 | 13,927 | 0 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | James Steven P | Director | Sell | U | 0.00 | 13,677 | 0 | 0 | 13.7 K to 0 (-100.00 %) |
Mar 13 2018 | CASC | Cascadian Therapeu ... | LOVE TED W | Director | Option Exercise | D | 0.00 | 13,927 | 0 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | LOVE TED W | Director | Sell | U | 0.00 | 37,394 | 0 | 0 | 37.4 K to 0 (-100.00 %) |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Fyfe Gwen A. | Director | Option Exercise | D | 0.00 | 13,927 | 0 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Fyfe Gwen A. | Director | Sell | U | 0.00 | 10,125 | 0 | 0 | 10.1 K to 0 (-100.00 %) |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Viswanathan Ravi | 10% Owner | Sell | U | 0.00 | 10,882,574 | 0 | 0 | 10.9 M to 0 (-100.00 %) |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Sonsini Peter W. | 10% Owner | Sell | U | 0.00 | 10,882,574 | 0 | 0 | 10.9 M to 0 (-100.00 %) |
Mar 13 2018 | CASC | Cascadian Therapeu ... | SANDELL SCOTT D | 10% Owner | Sell | U | 0.00 | 10,882,574 | 0 | 0 | 10.9 M to 0 (-100.00 %) |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Sakoda Jon | 10% Owner | Sell | U | 0.00 | 10,882,574 | 0 | 0 | 10.9 M to 0 (-100.00 %) |
Mar 13 2018 | CASC | Cascadian Therapeu ... | MOTT DAVID M | 10% Owner | Sell | U | 0.00 | 10,882,574 | 0 | 0 | 10.9 M to 0 (-100.00 %) |
Mar 13 2018 | CASC | Cascadian Therapeu ... | MAKOWER JOSHUA | 10% Owner | Sell | U | 0.00 | 10,882,574 | 0 | 0 | 10.9 M to 0 (-100.00 %) |
Mar 13 2018 | CASC | Cascadian Therapeu ... | PETERSON SCOTT ROBERT | Chief Scientific Of ... | Option Exercise | D | 0.00 | 155,500 | 0 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | PETERSON SCOTT ROBERT | Chief Scientific Of ... | Option Exercise | D | 0.00 | 14,000 | 0 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | PETERSON SCOTT ROBERT | Chief Scientific Of ... | Option Exercise | D | 0.00 | 11,300 | 0 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | PETERSON SCOTT ROBERT | Chief Scientific Of ... | Option Exercise | D | 3.99 | 65,000 | 259,350 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | PETERSON SCOTT ROBERT | Chief Scientific Of ... | Option Exercise | D | 4.64 | 51,200 | 237,568 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | PETERSON SCOTT ROBERT | Chief Scientific Of ... | Option Exercise | D | 6.90 | 54,167 | 373,752 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | PETERSON SCOTT ROBERT | Chief Scientific Of ... | Option Exercise | D | 21.06 | 41,667 | 877,507 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | PETERSON SCOTT ROBERT | Chief Scientific Of ... | Option Exercise | D | 10.56 | 25,000 | 264,000 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | PETERSON SCOTT ROBERT | Chief Scientific Of ... | Option Exercise | D | 10.44 | 25,000 | 261,000 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | PETERSON SCOTT ROBERT | Chief Scientific Of ... | Option Exercise | D | 28.44 | 8,334 | 237,019 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | PETERSON SCOTT ROBERT | Chief Scientific Of ... | Option Exercise | D | 41.52 | 8,334 | 346,028 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | PETERSON SCOTT ROBERT | Chief Scientific Of ... | Option Exercise | D | 19.92 | 8,334 | 166,013 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | PETERSON SCOTT ROBERT | Chief Scientific Of ... | Sell | U | 0.00 | 3,639 | 0 | 0 | 3.6 K to 0 (-100.00 %) |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Florence Anthony A. Jr. | 10% Owner | Sell | U | 0.00 | 10,882,574 | 0 | 0 | 10.9 M to 0 (-100.00 %) |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Azelby Robert | Director | Option Exercise | D | 0.00 | 13,927 | 0 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Azelby Robert | Director | Option Exercise | D | 0.00 | 12,437 | 0 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | SPIEGELMAN DANIEL K | Director | Option Exercise | D | 0.00 | 13,927 | 0 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | SPIEGELMAN DANIEL K | Director | Sell | U | 0.00 | 21,006 | 0 | 0 | 21 K to 0 (-100.00 %) |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Option Exercise | D | 0.00 | 250,000 | 0 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Option Exercise | D | 0.00 | 6,300 | 0 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Option Exercise | D | 0.00 | 15,500 | 0 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Option Exercise | D | 0.00 | 42,000 | 0 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Option Exercise | D | 3.99 | 60,000 | 239,400 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Option Exercise | D | 4.64 | 190,000 | 881,600 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Option Exercise | D | 7.08 | 474,810 | 3,361,655 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Sell | U | 0.00 | 56,787 | 0 | 0 | 56.8 K to 0 (-100.00 %) |
Mar 13 2018 | CASC | Cascadian Therapeu ... | BASKETT FOREST | 10% Owner | Sell | U | 0.00 | 10,882,574 | 0 | 0 | 10.9 M to 0 (-100.00 %) |
Mar 13 2018 | CASC | Cascadian Therapeu ... | BARRIS PETER J | 10% Owner | Sell | U | 0.00 | 10,882,574 | 0 | 0 | 10.9 M to 0 (-100.00 %) |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Growth Equity Opportunities IV ... | 10% Owner | Sell | U | 0.00 | 10,882,574 | 0 | 0 | 10.9 M to 0 (-100.00 %) |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Christianson Gary | Chief Operating Off ... | Option Exercise | D | 0.00 | 164,500 | 0 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Christianson Gary | Chief Operating Off ... | Option Exercise | D | 0.00 | 15,000 | 0 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Christianson Gary | Chief Operating Off ... | Option Exercise | D | 0.00 | 11,300 | 0 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Christianson Gary | Chief Operating Off ... | Option Exercise | D | 3.99 | 68,000 | 271,320 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Christianson Gary | Chief Operating Off ... | Option Exercise | D | 4.64 | 51,200 | 237,568 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Christianson Gary | Chief Operating Off ... | Option Exercise | D | 6.90 | 41,667 | 287,502 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Christianson Gary | Chief Operating Off ... | Option Exercise | D | 21.06 | 41,667 | 877,507 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Christianson Gary | Chief Operating Off ... | Option Exercise | D | 10.56 | 16,667 | 176,004 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Christianson Gary | Chief Operating Off ... | Option Exercise | D | 10.44 | 25,000 | 261,000 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Christianson Gary | Chief Operating Off ... | Option Exercise | D | 28.44 | 8,334 | 237,019 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Christianson Gary | Chief Operating Off ... | Option Exercise | D | 41.52 | 8,334 | 346,028 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Christianson Gary | Chief Operating Off ... | Option Exercise | D | 19.92 | 8,334 | 166,013 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Christianson Gary | Chief Operating Off ... | Sell | U | 0.00 | 6,515 | 0 | 0 | 6.5 K to 0 (-100.00 %) |
Mar 13 2018 | CASC | Cascadian Therapeu ... | HENNEY CHRISTOPHER S | Director | Option Exercise | D | 0.00 | 13,927 | 0 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | HENNEY CHRISTOPHER S | Director | Option Exercise | D | 6.36 | 25,000 | 159,000 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | HENNEY CHRISTOPHER S | Director | Sell | U | 0.00 | 60,185 | 0 | 0 | 60.2 K to 0 (-100.00 %) |
Mar 13 2018 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Option Exercise | D | 0.00 | 199,000 | 0 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Option Exercise | D | 0.00 | 16,500 | 0 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Option Exercise | D | 0.00 | 11,300 | 0 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Option Exercise | D | 3.99 | 75,000 | 299,250 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Option Exercise | D | 4.64 | 51,200 | 237,568 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Option Exercise | D | 6.90 | 50,000 | 345,000 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Option Exercise | D | 21.06 | 41,667 | 877,507 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Option Exercise | D | 10.56 | 16,667 | 176,004 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Option Exercise | D | 10.44 | 25,000 | 261,000 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Option Exercise | D | 28.44 | 8,334 | 237,019 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Option Exercise | D | 41.52 | 8,334 | 346,028 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Option Exercise | D | 19.92 | 8,334 | 166,013 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Option Exercise | D | 19.86 | 6,667 | 132,407 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Sell | U | 0.00 | 5,237 | 0 | 0 | 5.2 K to 0 (-100.00 %) |
Feb 22 2018 | CASC | Cascadian Therapeu ... | Viswanathan Ravi | 10% Owner | Option Exercise | C | 3.30 | 1,818,000 | 5,999,400 | 0 | |
Feb 22 2018 | CASC | Cascadian Therapeu ... | Viswanathan Ravi | 10% Owner | Buy | C | 3.30 | 1,818,000 | 5,999,400 | 10,882,574 | 9.1 M to 10.9 M (+20.06 %) |
Feb 22 2018 | CASC | Cascadian Therapeu ... | Sonsini Peter W. | 10% Owner | Option Exercise | C | 3.30 | 1,818,000 | 5,999,400 | 0 | |
Feb 22 2018 | CASC | Cascadian Therapeu ... | Sonsini Peter W. | 10% Owner | Buy | C | 3.30 | 1,818,000 | 5,999,400 | 10,882,574 | 9.1 M to 10.9 M (+20.06 %) |
Feb 22 2018 | CASC | Cascadian Therapeu ... | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 3.30 | 1,818,000 | 5,999,400 | 0 | |
Feb 22 2018 | CASC | Cascadian Therapeu ... | SANDELL SCOTT D | 10% Owner | Buy | C | 3.30 | 1,818,000 | 5,999,400 | 10,882,574 | 9.1 M to 10.9 M (+20.06 %) |
Feb 22 2018 | CASC | Cascadian Therapeu ... | Sakoda Jon | 10% Owner | Option Exercise | C | 3.30 | 1,818,000 | 5,999,400 | 0 | |
Feb 22 2018 | CASC | Cascadian Therapeu ... | Sakoda Jon | 10% Owner | Buy | C | 3.30 | 1,818,000 | 5,999,400 | 10,882,574 | 9.1 M to 10.9 M (+20.06 %) |
Feb 22 2018 | CASC | Cascadian Therapeu ... | Florence Anthony A. Jr. | 10% Owner | Option Exercise | C | 3.30 | 1,818,000 | 5,999,400 | 0 | |
Feb 22 2018 | CASC | Cascadian Therapeu ... | Florence Anthony A. Jr. | 10% Owner | Buy | C | 3.30 | 1,818,000 | 5,999,400 | 10,882,574 | 9.1 M to 10.9 M (+20.06 %) |
Feb 22 2018 | CASC | Cascadian Therapeu ... | BASKETT FOREST | 10% Owner | Option Exercise | C | 3.30 | 1,818,000 | 5,999,400 | 0 | |
Feb 22 2018 | CASC | Cascadian Therapeu ... | BASKETT FOREST | 10% Owner | Buy | C | 3.30 | 1,818,000 | 5,999,400 | 10,882,574 | 9.1 M to 10.9 M (+20.06 %) |
Feb 22 2018 | CASC | Cascadian Therapeu ... | BARRIS PETER J | 10% Owner | Option Exercise | C | 3.30 | 1,818,000 | 5,999,400 | 0 | |
Feb 22 2018 | CASC | Cascadian Therapeu ... | BARRIS PETER J | 10% Owner | Buy | C | 3.30 | 1,818,000 | 5,999,400 | 10,882,574 | 9.1 M to 10.9 M (+20.06 %) |
Feb 22 2018 | CASC | Cascadian Therapeu ... | Growth Equity Opportunities IV ... | 10% Owner | Option Exercise | C | 3.30 | 1,818,000 | 5,999,400 | 0 | |
Feb 22 2018 | CASC | Cascadian Therapeu ... | Growth Equity Opportunities IV ... | 10% Owner | Buy | C | 3.30 | 1,818,000 | 5,999,400 | 10,882,574 | 9.1 M to 10.9 M (+20.06 %) |
Feb 22 2018 | CASC | Cascadian Therapeu ... | Florence Anthony A. Jr. | 10% Owner | Option Exercise | C | 3.30 | 1,818,000 | 5,999,400 | 0 | |
Feb 22 2018 | CASC | Cascadian Therapeu ... | Florence Anthony A. Jr. | 10% Owner | Buy | C | 3.30 | 1,818,000 | 5,999,400 | 10,882,574 | 9.1 M to 10.9 M (+20.06 %) |
Feb 22 2018 | CASC | Cascadian Therapeu ... | BASKETT FOREST | 10% Owner | Option Exercise | C | 3.30 | 1,818,000 | 5,999,400 | 0 | |
Feb 22 2018 | CASC | Cascadian Therapeu ... | BASKETT FOREST | 10% Owner | Buy | C | 3.30 | 1,818,000 | 5,999,400 | 10,882,574 | 9.1 M to 10.9 M (+20.06 %) |
Feb 22 2018 | CASC | Cascadian Therapeu ... | BARRIS PETER J | 10% Owner | Option Exercise | C | 3.30 | 1,818,000 | 5,999,400 | 0 | |
Feb 22 2018 | CASC | Cascadian Therapeu ... | BARRIS PETER J | 10% Owner | Buy | C | 3.30 | 1,818,000 | 5,999,400 | 10,882,574 | 9.1 M to 10.9 M (+20.06 %) |
Feb 22 2018 | CASC | Cascadian Therapeu ... | Growth Equity Opportunities IV ... | 10% Owner | Option Exercise | C | 3.30 | 1,818,000 | 5,999,400 | 0 | |
Feb 22 2018 | CASC | Cascadian Therapeu ... | Growth Equity Opportunities IV ... | 10% Owner | Buy | C | 3.30 | 1,818,000 | 5,999,400 | 10,882,574 | 9.1 M to 10.9 M (+20.06 %) |
Feb 02 2018 | CASC | Cascadian Therapeu ... | Walker Luke Nathaniel | SVP, Clinical Devel ... | Option Exercise | A | 0.00 | 130,000 | 0 | 130,000 | |
Feb 02 2018 | CASC | Cascadian Therapeu ... | PETERSON SCOTT ROBERT | Chief Scientific Of ... | Option Exercise | A | 0.00 | 155,500 | 0 | 155,500 | |
Feb 02 2018 | CASC | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Option Exercise | A | 0.00 | 250,000 | 0 | 250,000 | |
Feb 02 2018 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Option Exercise | A | 0.00 | 199,000 | 0 | 199,000 | |
Feb 02 2018 | CASC | Cascadian Therapeu ... | Christianson Gary | Chief Operating Off ... | Option Exercise | A | 0.00 | 164,500 | 0 | 164,500 | |
Jan 16 2018 | CASC | Cascadian Therapeu ... | Walker Luke Nathaniel | SVP, Clinical Devel ... | Option Exercise | M | 0.00 | 1,950 | 0 | 5,850 | |
Jan 16 2018 | CASC | Cascadian Therapeu ... | Walker Luke Nathaniel | SVP, Clinical Devel ... | Payment of Exercise | F | 3.92 | 637 | 2,497 | 5,303 | 5.9 K to 5.3 K (-10.72 %) |
Jan 16 2018 | CASC | Cascadian Therapeu ... | Walker Luke Nathaniel | SVP, Clinical Devel ... | Buy | M | 0.00 | 1,950 | 0 | 5,940 | 4 K to 5.9 K (+48.87 %) |
Jan 16 2018 | CASC | Cascadian Therapeu ... | PETERSON SCOTT ROBERT | Chief Scientific Of ... | Option Exercise | M | 0.00 | 2,825 | 0 | 8,475 | |
Jan 16 2018 | CASC | Cascadian Therapeu ... | PETERSON SCOTT ROBERT | Chief Scientific Of ... | Payment of Exercise | F | 3.92 | 923 | 3,618 | 3,639 | 4.6 K to 3.6 K (-20.23 %) |
Jan 16 2018 | CASC | Cascadian Therapeu ... | PETERSON SCOTT ROBERT | Chief Scientific Of ... | Buy | M | 0.00 | 2,825 | 0 | 4,562 | 1.7 K to 4.6 K (+162.64 %) |
Jan 16 2018 | CASC | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Option Exercise | M | 0.00 | 10,500 | 0 | 31,500 | |
Jan 16 2018 | CASC | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Payment of Exercise | F | 3.92 | 3,429 | 13,442 | 56,787 | 60.2 K to 56.8 K (-5.69 %) |
Jan 16 2018 | CASC | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Buy | M | 0.00 | 10,500 | 0 | 60,216 | 49.7 K to 60.2 K (+21.12 %) |
Jan 16 2018 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Option Exercise | M | 0.00 | 2,825 | 0 | 8,475 | |
Jan 16 2018 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Payment of Exercise | F | 3.92 | 923 | 3,618 | 5,237 | 6.2 K to 5.2 K (-14.98 %) |
Jan 16 2018 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Buy | M | 0.00 | 2,825 | 0 | 6,160 | 3.3 K to 6.2 K (+84.71 %) |
Jan 16 2018 | CASC | Cascadian Therapeu ... | Christianson Gary | Chief Operating Off ... | Option Exercise | M | 0.00 | 2,825 | 0 | 8,475 | |
Jan 16 2018 | CASC | Cascadian Therapeu ... | Christianson Gary | Chief Operating Off ... | Payment of Exercise | F | 3.92 | 923 | 3,618 | 6,515 | 7.4 K to 6.5 K (-12.41 %) |
Jan 16 2018 | CASC | Cascadian Therapeu ... | Christianson Gary | Chief Operating Off ... | Buy | M | 0.00 | 2,825 | 0 | 7,438 | 4.6 K to 7.4 K (+61.24 %) |
Nov 13 2017 | CASC | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Option Exercise | A | 0.00 | 6,300 | 0 | 6,300 | |
Sep 26 2017 | CASC | Cascadian Therapeu ... | SPIEGELMAN DANIEL K | Director | Option Exercise | M | 0.00 | 2,375 | 0 | 0 | |
Sep 26 2017 | CASC | Cascadian Therapeu ... | SPIEGELMAN DANIEL K | Director | Payment of Exercise | F | 3.94 | 594 | 2,340 | 21,006 | 21.6 K to 21 K (-2.75 %) |
Sep 26 2017 | CASC | Cascadian Therapeu ... | SPIEGELMAN DANIEL K | Director | Buy | M | 0.00 | 2,375 | 0 | 21,600 | 19.2 K to 21.6 K (+12.35 %) |
Sep 26 2017 | CASC | Cascadian Therapeu ... | LOVE TED W | Director | Option Exercise | M | 0.00 | 2,375 | 0 | 0 | |
Sep 26 2017 | CASC | Cascadian Therapeu ... | LOVE TED W | Director | Payment of Exercise | F | 3.94 | 594 | 2,340 | 37,394 | 38 K to 37.4 K (-1.56 %) |
Sep 26 2017 | CASC | Cascadian Therapeu ... | LOVE TED W | Director | Buy | M | 0.00 | 2,375 | 0 | 37,988 | 35.6 K to 38 K (+6.67 %) |
Sep 26 2017 | CASC | Cascadian Therapeu ... | James Steven P | Director | Option Exercise | M | 0.00 | 2,375 | 0 | 0 | |
Sep 26 2017 | CASC | Cascadian Therapeu ... | James Steven P | Director | Payment of Exercise | F | 3.94 | 594 | 2,340 | 13,677 | 14.3 K to 13.7 K (-4.16 %) |
Sep 26 2017 | CASC | Cascadian Therapeu ... | James Steven P | Director | Buy | M | 0.00 | 2,375 | 0 | 14,271 | 11.9 K to 14.3 K (+19.96 %) |
Sep 26 2017 | CASC | Cascadian Therapeu ... | HENNEY CHRISTOPHER S | Director | Option Exercise | M | 0.00 | 2,375 | 0 | 0 | |
Sep 26 2017 | CASC | Cascadian Therapeu ... | HENNEY CHRISTOPHER S | Director | Payment of Exercise | F | 3.94 | 594 | 2,340 | 60,185 | 60.8 K to 60.2 K (-0.98 %) |
Sep 26 2017 | CASC | Cascadian Therapeu ... | HENNEY CHRISTOPHER S | Director | Buy | M | 0.00 | 2,375 | 0 | 60,779 | 58.4 K to 60.8 K (+4.07 %) |
Sep 20 2017 | CASC | Cascadian Therapeu ... | PETERSON SCOTT ROBERT | Chief Scientific Of ... | Option Exercise | A | 0.00 | 14,000 | 0 | 14,000 | |
Sep 20 2017 | CASC | Cascadian Therapeu ... | PETERSON SCOTT ROBERT | Chief Scientific Of ... | Option Exercise | A | 3.99 | 65,000 | 259,350 | 65,000 | |
Sep 20 2017 | CASC | Cascadian Therapeu ... | Walker Luke Nathaniel | SVP, Clinical Devel ... | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
Sep 20 2017 | CASC | Cascadian Therapeu ... | Walker Luke Nathaniel | SVP, Clinical Devel ... | Option Exercise | A | 3.99 | 50,000 | 199,500 | 50,000 | |
Sep 20 2017 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Option Exercise | A | 0.00 | 16,500 | 0 | 16,500 | |
Sep 20 2017 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Option Exercise | A | 3.99 | 75,000 | 299,250 | 75,000 | |
Sep 20 2017 | CASC | Cascadian Therapeu ... | Christianson Gary | Chief Operating Off ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
Sep 20 2017 | CASC | Cascadian Therapeu ... | Christianson Gary | Chief Operating Off ... | Option Exercise | A | 3.99 | 68,000 | 271,320 | 68,000 |